SANOFI-AVENTIS DEUTSCHLAND GMBH - Germany 

This institution has been merged with: SANOFIAVENTIS.

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:900-1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 13
As coordinator: 0
As participant: 13
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 18.249.993 0 1
2017 0 53.797.881 0 4
2016 0 27.164.781 249.216 3
2015 0 21.668.972 249.216 2
2014 0 587.134 0 1
2012 0 6.978.147 366.127 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
NOVO NORDISK6
ASTRAZENECA AB4
ELI LILLY AND COMPANY LIMITED4
JANSSEN PHARMACEUTICA NV4
ACADEMISCH ZIEKENHUIS GRONINGEN3
ACADEMISCH ZIEKENHUIS LEIDEN3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
KAROLINSKA INSTITUTE3
LUNDS UNIVERSITET3
MEDIZINISCHE UNIVERSITAET WIEN3
PFIZER LIMITED3
STICHTING KATHOLIEKE UNIVERSITEIT3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF NEWCASTLE UPON TYNE3
ABBVIE INC2
ANTAROS MEDICAL AB2
BAYER AKTIENGESELLSCHAFT2
BAYER PHARMA2
BRISTOLMYERS SQUIBB COMPANY CORP2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
EBERHARD KARLS UNIVERSITAET TUEBINGEN2
INSTITUT DE RECHERCHES SERVIER2
ITASUOMEN YLIOPISTO2
JDRF INTERNATIONAL2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KING'S COLLEGE LONDON2
LINKOEPING UNIVERSITY2
LIPOTYPE2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NOVARTIS PHARMA2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
TECHNISCHE UNIVERSITAET DRESDEN2
THE UNIVERSITY OF SHEFFIELD2
UCB BIOPHARMA2
UNIVERSITA DI PISA2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITE DE LAUSANNE2
UNIVERSITE LIBRE DE BRUXELLES2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF LEEDS2
UNIVERZA V LJUBLJANI2
ABBVIE DEUTSCHLAND GMBH & CO KG1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACREO AB1
ALCYOMICS1
ALLERGAN LIMITED1
ANOCCA AB1
APITOPE INTERNATIONAL NV1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION LYON BIOPOLE1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA UK LIMITED1
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1
BAYER1
BIOASCENT DISCOVERY LIMITED1
BIOXYDYN LIMITED1
BRUKER BIOSPIN MRI1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CARDIFF UNIVERSITY1
CENTRE HOSPITALIER DE LUXEMBOURG1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CERTARA UK LIMITED1
CHALMERS TEKNISKA HOEGSKOLA AB1
CHR HANSEN1
CHU HOPITAUX DE BORDEAUX1
CLARIVATE ANALYTICS LIMITED1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN1
ECHOSENS1
EDELRIS SAS1
EISAI CO1
ELLEGAARD GOTTINGEN MINIPIGS AS1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EXALENZ BIOSCIENCE1
F HOFFMANNLA ROCHE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FONDAZIONE PER L ISTITUTO DI RICERCA IN BIOMEDICINA1
FONDS NATIONAL DE LA RECHERCHE1
FORSCHUNGSZENTRUM JULICH1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED1
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM1
GE HEALTHCARE LIMITED1
GENFIT1
GILEAD SCIENCES INC1
GRUNENTHAL1
HANNOVERSCHE KINDERHEILANSTALT1
HASKOLI ISLANDS1
HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT1

Constancy:

Total number of partners: 281
Partner loyalty:
Frequent Partner: (> 2 projects): 61
Rare Partner: 220
Frequent / Rare Partner Ratio: 0.28

Project overview:

Start dateProjectacronymrolefundingpartners
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2016-01-01ISOTOPIC LABELING FOR DRUG INNOVATION ISOTOPICSparticipant3.948.84413
2015-11-01Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797 INNODIAparticipant17.630.00036
2015-01-01Rapid Bioprocess Development Biorapidparticipant4.038.9729
2014-01-01Complementary Synthetic Strategies toward Heterocyclic Boronates COSSHNETparticipant587.1342
2012-11-01Coordinating Action Systems Medicine – Implementation of Systems Medicine across Europe CASYMparticipant2.996.47722
2012-01-01European Training Network for Excellence in Molecular Imaging in Diabetes BetaTrainparticipant3.981.67010